Trials / Conditions / Respiratory Tract Disease

Respiratory Tract Disease

30 registered clinical trials studyying Respiratory Tract Disease — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Antibiotic Stewardship in AECOPD Through CRP-Guided Management NCT05286918	The University of Hong Kong	N/A
Unknown	Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions NCT05330507	Convexity Scientific Inc	—
Terminated	(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations NCT05241873	Blueprint Medicines Corporation	Phase 1
Completed	Recording of Multiple Nights Using a New Contactless Device (Sleepiz One Connect) in Obstructive Sleep Apnea NCT05134402	Samuel Tschopp	—
Unknown	Partially Hydrolyzed Guar Gum (PHGG) for Amelioration of Chronic Obstructive Pulmonary Disease (COPD) NCT05126654	Fu Jen Catholic University Hospital	N/A
Terminated	(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC NCT04862780	Blueprint Medicines Corporation	Phase 1
Unknown	Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy in Patients With Obstructive Sleep NCT04729478	ethisch.comite@uza.be	N/A
Terminated	A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH NCT04084678	United Therapeutics	Phase 3
Completed	Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study NCT04234152	St. Justine's Hospital	N/A
Terminated	SILtuximab in Viral ARds (SILVAR) Study NCT04616586	RECORDATI GROUP	Phase 3
Unknown	Houston "Breathe Easy" Healthy Homes-Based Model for Multifamily Rental Communities NCT05345080	Baylor College of Medicine	N/A
Terminated	A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer NCT04222972	Hoffmann-La Roche	Phase 3
Completed	Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 NCT04476979	Assistance Publique - Hôpitaux de Paris	Phase 2
Unknown	Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration NCT04627623	Medical University of Silesia	—
Unknown	Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 NCT04365101	Celularity Incorporated	Phase 1 / Phase 2
Unknown	Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19) NCT04365166	Direction Centrale du Service de Santé des Armées	—
Enrolling By Invitation	A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Exten NCT03683186	United Therapeutics	Phase 3
Completed	A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients NCT03626688	United Therapeutics	Phase 3
Unknown	Evaluation of the Respiratory Function in Renal Transplanted Children NCT03571542	Nantes University Hospital	N/A
Completed	Comparison of Two Telemonitoring Auto-titrating Modalities in OSA Patients NCT03734341	Basque Health Service	N/A
Completed	Centralized Reminder Recall - Flu RCT2 NCT03294473	University of California, Los Angeles	N/A
Completed	Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adult NCT03321968	Medicago	Phase 3
Terminated	A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic NCT03309358	Synspira, Inc.	Phase 1
Completed	A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC NCT03134872	Jiangsu HengRui Medicine Co., Ltd.	Phase 3
Unknown	A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC NCT03085069	Jiangsu HengRui Medicine Co., Ltd.	Phase 2
Completed	Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Can NCT03037385	Hoffmann-La Roche	Phase 1 / Phase 2
Completed	Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel NCT03331991	Abt Associates	—
Terminated	Identify Genetic Variations That Affect The Ability of Patients To Metabolize Drugs Through Metabolic Pathways NCT02525887	Bracane Company	—
Completed	Intranasal Ketamine as a Sedative for Venipuncture NCT02929524	Hospital de Clinicas de Porto Alegre	Phase 2 / Phase 3
Unknown	Cpap at Delivery Room for Preterm Infants NCT01024361	University of Sao Paulo	Phase 4